Statistical flag only — not an accusation of fraud
⚠️ This provider averages 623 services per working day — physically unusual for an individual practitioner
Based on 1.6M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $16.1M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 623 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 265% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 68/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 101% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $35.16 | $6.54 | 5.38x | $28.62 | $876.3K | 133.9K | 48 |
| 2015 | $26.60 | $6.90 | 3.86x | $19.70 | $945.2K | 137.1K | 43 |
| 2016 | $27.27 | $6.71 | 4.06x | $20.56 | $971.7K | 144.7K | 43 |
| 2017 | $24.48 | $6.00 | 4.08x | $18.48 | $813.9K | 135.6K | 39 |
| 2018 | $26.81 | $6.76 | 3.97x | $20.05 | $693.5K | 102.6K | 42 |
| 2019 | $34.72 | $8.70 | 3.99x | $26.02 | $1.4M | 159.9K | 47 |
| 2020 | $43.13 | $11.77 | 3.66x | $31.36 | $2.1M | 181.0K | 57 |
| 2021 | $53.77 | $14.21 | 3.78x | $39.56 | $2.3M | 161.2K | 62 |
| 2022 | $56.70 | $15.07 | 3.76x | $41.63 | $2.8M | 183.7K | 60 |
| 2023 | $56.26 | $14.71 | 3.82x | $41.55 | $3.2M | 217.4K | 63 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 75.8K | $3.0M | $39.93 | 2.66x |
| J0897 | Injection, denosumab, 1 mg | 115.1K | $1.7M | $14.52 | 2.91x |
| J2505 | Injection, pegfilgrastim, 6 mg | 562 | $1.6M | $2.9K | 4.03x |
| J9299 | Injection, nivolumab, 1 mg | 61.8K | $1.4M | $23.02 | 2.50x |
| J9312 | Injection, rituximab, 10 mg | 9.3K | $637.6K | $68.81 | 3.01x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 17.8K | $630.0K | $35.35 | 2.46x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 880 | $618.0K | $702.30 | 6.07x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 9.8K | $512.1K | $52.22 | 2.48x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 4.8K | $472.6K | $99.18 | 3.59x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 548.0K | $460.0K | $0.84 | 3.55x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 31.5K | $285.0K | $9.06 | 5.12x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 3.4K | $282.6K | $83.43 | 2.38x |
| J9035 | Injection, bevacizumab, 10 mg | 5.0K | $282.2K | $56.25 | 2.98x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 386 | $275.4K | $713.38 | 2.22x |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 1.6K | $247.4K | $153.49 | 6.98x |
| J9041 | Injection, bortezomib, 0.1 mg | 7.9K | $205.7K | $25.93 | 4.05x |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 3.5K | $191.2K | $54.47 | 2.83x |
| J9173 | Injection, durvalumab, 10 mg | 3.1K | $189.6K | $62.09 | 2.34x |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 1.9K | $183.4K | $98.58 | 10.65x |
| J2469 | Injection, palonosetron hcl, 25 mcg | 17.0K | $178.7K | $10.54 | 10.24x |
This provider submits charges 3.92 times higher than what Medicare actually pays.
A markup ratio of 3.92x means for every $100 Medicare pays, this provider initially charges $392. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in SC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Renwick Goldberg, MD | Myrtle Beach, SC | $38.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data